Cargando…

Landscape of Congenital Adrenal Hyperplasia Newborn Screening in the United States

Newborn screening (NBS) is a state-based public health program that aims to identify newborns at risk of certain disorders in the first days after birth to prevent permanent disability or death. Disorders on the Health and Human Services Federal Advisory Committee’s Recommended Uniform Screening Pan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edelman, Sari, Desai, Hiral, Pigg, Trey, Yusuf, Careema, Ojodu, Jelili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569894/ https://www.ncbi.nlm.nih.gov/pubmed/33239590 http://dx.doi.org/10.3390/ijns6030064

Ejemplares similares

The Landscape of Severe Combined Immunodeficiency Newborn Screening in the United States in 2020: A Review of Screening Methodologies and Targets, Communication Pathways, and Long-Term Follow-Up Practices
por: Sheller, Ruthanne, et al.
Publicado: (2020)

Newborn Screening Practices for Beta-Thalassemia in the United States
por: Bender, Michael A., et al.
Publicado: (2021)

Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017
por: Sontag, Marci K., et al.
Publicado: (2020)

Development of National Newborn Screening Quality Indicators in the United States
por: Yusuf, Careema, et al.
Publicado: (2019)

Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
por: Hale, Kshea, et al.
Publicado: (2021)

Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
por: Gaviglio, Amy, et al.
Publicado: (2023)

Newborn Screening Practices and Alpha-Thalassemia Detection — United States, 2016
por: Bender, M.A., et al.
Publicado: (2020)

Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository
por: Sontag, Marci K., et al.
Publicado: (2020)

NewSTEPs: The Establishment of a National Newborn Screening Technical Assistance Resource Center
por: Ojodu, Jelili, et al.
Publicado: (2017)

Newborn screening for congenital adrenal hyperplasia in New York State
por: Pearce, Melissa, et al.
Publicado: (2016)

Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
por: Bialk, Eric R., et al.
Publicado: (2019)

Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia
por: Navardauskaitė, Rūta, et al.
Publicado: (2021)

Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States
por: Speiser, Phyllis W., et al.
Publicado: (2020)

Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010–2018
por: Singh, Sikha, et al.
Publicado: (2023)

Landscape of Adrenal Tumours in Patients with Congenital Adrenal Hyperplasia
por: Carsote, Mara, et al.
Publicado: (2023)

Newborn Screening for Congenital Adrenal Hyperplasia: Review of Factors Affecting Screening Accuracy
por: Held, Patrice K., et al.
Publicado: (2020)

Moderate congenital adrenal hyperplasia in two girls diagnosed by newborn screening
por: Banaszak-Ziemska, Magdalena, et al.
Publicado: (2021)

Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance
por: Sontag, Marci K., et al.
Publicado: (2018)

Results from 28 Years of Newborn Screening for Congenital Adrenal Hyperplasia in Sapporo
por: Morikawa, Shuntaro, et al.
Publicado: (2014)

Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia
por: Grosse, Scott D., et al.
Publicado: (2020)

Congenital Adrenal Hyperplasias Presenting in the Newborn and Young Infant
por: Balsamo, Antonio, et al.
Publicado: (2020)

Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
por: Hale, Kshea, et al.
Publicado: (2020)

Establishing a National Community of Practice for Newborn Screening Follow-Up
por: Darby, Erin, et al.
Publicado: (2021)

Results from 28 years of newborn screening for congenital adrenal hyperplasia in Sapporo City
por: Ishizu, Katsura, et al.
Publicado: (2013)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan
por: Tsuji-Hosokawa, Atsumi, et al.
Publicado: (2021)

2023 APHL/ISNS Newborn Screening Symposium
por: Olney, Richard S., et al.
Publicado: (2023)

Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence
por: Miranda, Mirela Costa De, et al.
Publicado: (2019)

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
por: de Hora, Mark R., et al.
Publicado: (2022)

The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison Between Screened and Unscreened Cohorts
por: de Miranda, Mirela Costa, et al.
Publicado: (2021)

Congenital adrenal hyperplasia
por: Dessinioti, Cleo, et al.
Publicado: (2009)

Congenital Adrenal Hyperplasia
por: Speiser, Phyllis W.
Publicado: (2015)

Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia
por: Tieh, Peter Yuk, et al.
Publicado: (2016)

Corrigendum for “Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence”
Publicado: (2021)

Neonatal Screening for Congenital Adrenal Hyperplasia in Indian Newborns with Reflex Genetic Analysis of 21-Hydroxylase Deficiency
por: Tippabathani, Jayakrishna, et al.
Publicado: (2023)

Differences in Hyperandrogenism Related to Early Detection of Non-Classical Congenital Adrenal Hyperplasia on Second Newborn Screen
por: McCann-Crosby, Bonnie, et al.
Publicado: (2023)

Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2020)

Editorial: Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey
por: Bereket, Abdullah
Publicado: (2019)

Screening for Anxiety and Depression in Children with Congenital Adrenal Hyperplasia
por: Jacob, Marianne, et al.
Publicado: (2023)

Evaluation of a Two-Tier Screening Pathway for Congenital Adrenal Hyperplasia in the New South Wales Newborn Screening Programme
por: Lai, Fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0kf73u2uvpae482tk8jk75mpn2